Kuros Biosciences AG (LON:0RHR)

Kuros Biosciences AG Statistics

Total Valuation

LON:0RHR has a market cap or net worth of GBP 1.03 billion. The enterprise value is 1.01 billion.

Market Cap	1.03B
Enterprise Value	1.01B

Important Dates

The next estimated earnings date is Tuesday, March 10, 2026.

Earnings Date	Mar 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	39.15M
Shares Outstanding	n/a
Shares Change (YoY)	+36.07%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	24.02%
Owned by Institutions (%)	15.48%
Float	29.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	78.77
PS Ratio	10.82
PB Ratio	14.59
P/TBV Ratio	32.09
P/FCF Ratio	n/a
P/OCF Ratio	1,363.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 162.55, with an EV/FCF ratio of -1,633.02.

EV / Earnings	-181.42
EV / Sales	10.20
EV / EBITDA	162.55
EV / EBIT	273.56
EV / FCF	-1,633.02

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.02.

Current Ratio	2.25
Quick Ratio	1.68
Debt / Equity	0.02
Debt / EBITDA	0.28
Debt / FCF	-2.66
Interest Coverage	0.72

Financial Efficiency

Return on equity (ROE) is -8.62% and return on invested capital (ROIC) is 3.43%.

Return on Equity (ROE)	-8.62%
Return on Assets (ROA)	2.57%
Return on Invested Capital (ROIC)	3.43%
Return on Capital Employed (ROCE)	4.65%
Revenue Per Employee	600,345
Profits Per Employee	-35,242
Employee Count	122
Asset Turnover	1.10
Inventory Turnover	1.14

Taxes

In the past 12 months, LON:0RHR has paid 988,460 in taxes.

Income Tax	988,460
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.86% in the last 52 weeks. The beta is 0.92, so LON:0RHR's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-5.86%
50-Day Moving Average	27.39
200-Day Moving Average	25.02
Relative Strength Index (RSI)	39.80
Average Volume (20 Days)	33,693

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RHR had revenue of GBP 94.85 million and -5.57 million in losses. Loss per share was -0.12.

Revenue	94.85M
Gross Profit	84.14M
Operating Income	3.54M
Pretax Income	-4.42M
Net Income	-5.57M
EBITDA	5.35M
EBIT	3.54M
Loss Per Share	-0.12

Balance Sheet

The company has 16.93 million in cash and 1.64 million in debt, giving a net cash position of 15.28 million.

Cash & Cash Equivalents	16.93M
Total Debt	1.64M
Net Cash	15.28M
Net Cash Per Share	n/a
Equity (Book Value)	70.35M
Book Value Per Share	1.75
Working Capital	30.98M

Cash Flow

In the last 12 months, operating cash flow was 752,588 and capital expenditures -1.37 million, giving a free cash flow of -618,590.

Operating Cash Flow	752,588
Capital Expenditures	-1.37M
Free Cash Flow	-618,590
FCF Per Share	n/a

Margins

Gross margin is 88.70%, with operating and profit margins of 3.73% and -5.87%.

Gross Margin	88.70%
Operating Margin	3.73%
Pretax Margin	-4.66%
Profit Margin	-5.87%
EBITDA Margin	5.64%
EBIT Margin	3.73%
FCF Margin	n/a

Dividends & Yields

LON:0RHR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.07%
Shareholder Yield	-36.07%
Earnings Yield	-0.54%
FCF Yield	-0.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RHR has an Altman Z-Score of 14.95 and a Piotroski F-Score of 5.

Altman Z-Score	14.95
Piotroski F-Score	5